[EFFECT] Connect Biopharma Holdings Limited American SEC Filing

Rhea-AI Filing Summary

Connect Biopharma Holdings has received a Notice of Effectiveness from the SEC for their Form F-3 registration statement (File No. 333-287918), which became effective on June 26, 2025 at 4:00 P.M.

Form F-3 is a securities registration statement used by foreign companies to register various types of securities offerings in the United States. The effectiveness of this filing indicates that Connect Biopharma can now proceed with their planned securities offering as outlined in the registration statement.

This development is significant for investors as it enables the company to access U.S. capital markets and potentially raise additional funds through various securities offerings, including debt or equity securities, depending on the specifics outlined in the F-3 registration statement.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 26, 2025 4:00 P.M.

Form:

F-3

CIK:	0001835268
Company Name:	Connect Biopharma Holdings Ltd
File Number:	333-287918